Tesco shares: despite nearly doubling, shares are still not expensive

Despite nearly doubling from 2022 lows, Tesco shares are still not expensive and present good value for the long-term holder.

Tesco’s share price chart is something to behold. Notwithstanding the obligatory bouts of profit-taking that produced drawdowns of no more than 20%, Tesco shares have been grinding nicely higher since touching 200p in October 2022.

Although shares dipped during the volatility in early August, it has been one-way traffic to the upside since, with only two down days since the beginning of August.

The relative safety of Tesco’s reliable cash flows has proved to be a draw for investors, not only during the recent spate of volatility but also throughout the interest rate hiking cycle and high levels of inflation.

Tesco has managed to pass on higher input costs through a careful pricing strategy, which saw group revenues grow 7.4% from FY23 to FY24 while operating margins grew 42bps to 4.2%. This was no mean feat, given that inflation ran hot for most of that period.

Subsequent evidence of strong leadership can be found in the successful navigation of easing inflation and the growth of Tesco’s market shares.

Sales grew 3.4% in the group’s first quarter as Tesco’s market shares grew 52bps to 27.6%. Tesco are locked into a bitter war of attrition on price with discounters Aldi and Lidl, which threatened Tesco’s market share as shoppers sought out value options amid the cost of living crisis.

However, the deployment budget ranges to rival the discounters have been a big success for Tesco and the mix of premium and budget options all under one roof has ensured market share gains and the maintenance of margins.

With pressures on households now easing with the cutting of interest rates, Tesco may see an opportunity in its Finest range, and households may find a little more cash in their pockets.

The positive environment for Tescos has been reflected in its share price, which is now up 26% year-to-date. However, this year’s gains don’t mean the stock hasn’t got further to run.

Tesco trades at 14.4x forward earnings. This isn’t particularly good value, but it’s certainly not expensive and doesn’t reflect the quality of the stock.

For a capital-intensive business such as Tesco, a Return on Capital Employed of 10 demonstrates its efficient operations. The 3.3% dividend yield is covered 1.9x by earnings, and Tesco is a cash-generating machine with free cash flow remaining in the $2bn range.

We wouldn’t suggest jumping straight into shares at current levels, but they are certainly one for the watchlist.

Vistry Group is emerging as the top FTSE 350 housebuilder pick

After releasing its half-year report, it’s clear Vistry’s shift in approach in 2023 is starting to pay off, and shareholders are set to see the rewards.

Vistry Group believes they are on course to deliver 18,000 completions this year, significantly ahead of last year’s 16,118 completions. That is a big jump, especially in this market.

The company’s success ultimately lies in its decision to focus on areas of the housing market where they saw the highest demand and some level of support for the end occupier. 

Vistry’s ’partnerships’ model involves the group working closely with local authorities to provide housing to both not-for-profit and for-profit local authorities, and the private rented sector. The company will still sell to the consumer market through consumer-facing brands Bovis Homes, Linden Homes and Countryside Homes. The group said it’s targeting 35% of its homes to be sold on the open market.

There is a huge undersupply of social and affordable housing in the UK. By working on a tender basis with local authorities, Vistry is completely sidestepping the problems many buyers face with affordability and higher interest rates to deliver to ready, willing, and able buyers in councils and local authorities.

The private rented sector is particularly interesting area given that more people are renting for longer.

It’s very likely Vistry’s success was manifested long before Keir Starmer entered Number 10 Downing Street, but his victory and subsequent pledges have really fired up the afterburners for Vistry.

In its half year report, Vistry CEO Greg Fitzgerald, said;

“The Group’s growth strategy and greater delivery of affordable housing is well aligned to the new Government’s ambitions to address the country’s housing crisis, and uniquely positions Vistry to play a key role in delivering the Government’s new housing targets.”

You shouldn’t underestimate the tailwinds the Labour government will provide Vistry.

The private housebuilding sector has been slow to build houses and has been nowhere near delivering the number of homes the UK needs. Sure, more traditional homebuilders will play an important part in meeting Labour’s 1.5 million new homes target, but the major opportunity lies in low-cost, affordable homes, many of which will be put out to tender by councils.

In this scenario, Vistry doesn’t have to worry too much about finding buyers for the homes; all they have to do is simply build what they are instructed to. This has helped them achieve their growth in completions and is likely to continue to do so.

In addition, Vistry’s developments provide them with homes for private sale through their brands, such as Bovis Homes, allowing them to pursue greater margins from the houses not allocated to local authorities.

The potential to scale this model is material and is core to Vistry’s investment case. 

Vistry’s merit lies not only in its customer base and political events, which play straight into their hands, but also in the valuation the company offers compared to its peers.

With shares at 1,345p, Vistry trades at 15x forward earnings, significantly below Persimmon (19.4x), Barratt Developments (18.3x), and Taylor Wimpey (18.9x). This seems an unfair discount to its peers.

JP Morgan analysts seem to agree and have recently increased its Vistry share price target to 1,550p.

AIM movers: Andrada Mining secures Chilean partner and Eurasia Mining returns from suspension

9

Chilean lithium producer SQM is earning an initial 40% interest in the Lithium Ridge project in Namibia, which is operated by Andrada Mining (LON: ATM). There will be a $500,000 participation fee and an additional $1.5m with an option to invest $20m over less than four years to earn the 40% interest. The stake could be increased to 50%. A one-off success fee will be payable to Andrada Mining once a JORC compliant mineral resource estimate exceeds 40 million tonnes. The share price increased 18.1% to 3.75p.

Autoantibody profiling company Oncimmune (LON: ONC) says revenues will grow substantially following recent contract gains. Revenues for the year to August 2024 were £3m and growth this year should enable the company to achieve profitability. The share price rose 16.5% to 22.6p.

Katoro Gold (LON: KAT) has bought White Pine, a Canadian uranium exploration project. There is “an intense radiometric signature over the project, extending at least 14km”. This is the first exposure of the company to uranium exploration. The share price improved 15% to 0.115p.

Trading in Eurasia Mining (LON: EUA) shares has resumed following the publication of 2023 accounts late on Friday. Net cash was £1.1m at the end of 2023. The company has also agreed a one year working capital facility for up to £2.5m. The loan lasts until next August and is convertible at 2.7p/share. There are five tranches with around £1m of the loan dependent on a term sheet to sell the Russian asset. The lender will receive a payment of 12.5% of the facility, plus 5% of any draw downs, in shares at 2.3p each. The share price gained 12.8% to 2.6p.

FALLERS

Armadale Capital (LON: ACP) plans to open historic workings at the Canyon silver project in Idaho by widening the tunnels. The conditions have been more difficult than expected and this has caused delays. The share price dived 15.4% to 0.275p.

Oil and gas explorer Bowleven (LON: BLVN) is declining ahead of its departure from AIM on 24 September. The share price fell 11.1% to 0.2p, although it is still above its 2024 low.

Rockfire Resources (LON: ROCK) reported interim figures showing cash of £510,000 at the end of June 2024. The Molai zinc project in Greece has increased its resource to 15 million inferred tonnes at an average grade of 9.96% zinc equivalent. The farm-in partner for the Lighthouse and Kookaburra precious metals project in Australia failed to spend the minimum required. The share price lost some of last week’s gains and is down 6.98% to 0.2p.

Lupus treatment developer ImmuPharma (LON: IMM) had £1.1m in cash at the end of June 2024. There was a reduced loss in the first half, mainly due to lower R&D spending. Management is concentrating on partnership and commercial deals. Warrants held to subscribe for shares in Incanthera (LON: INC) at 9.5p each have been extended to the end of March 2025 in return for a £75,0000 payment by ImmuPharma. The share price dipped 2.77% to 1.4925p.

FTSE 100 bounces as economic concerns subside

The FTSE 100 gained on Monday after investors used the weekend to reflect on the economic outlook and evidently concluded that last week’s soft jobs report didn’t warrant selling to the extent that was witnessed after the last jobs report in early August.

“The FTSE 100 got off to a strong start on Monday, helped by strength in the resources space as oil prices bounced from their recent lows,” said AJ Bell investment director Russ Mould.

“The index had endured some weakness last Friday as US non-farm payrolls came in below expectations. The outcome seemed to cause the market concern that the US economy is headed for a hard landing after all, as the Federal Reserve readies its first interest rate cut of the current cycle.

After two years of inflation and monetary policy dominating the macro narrative, growth is firmly at the forefront of investor thinking.

Investors were able to take high inflation and rising interest rates in their stride because, despite persistent predictions to the contrary, growth remained robust over the past two years. 

Job creation in the US was strong, and the economy ticked along very nicely. However, this looks set to change, and the potential implications for company earnings have sparked a wave of concern through markets. 

The doomsayers will highlight slowing job creation and historical correlations with growth rates, while the more optimistic market participant will look to the Federal Reserve, Bank of England, ECB, and current interest rates and conclude major central banks have plenty of space to ease policy and support their respective economies. 

These are the factors markets will tussle over in the coming weeks. 

Entain

In London, Entain led the FTSE 100 higher with a 5% gain after the betting company alluded to improving trading conditions in the second half of the year as the new CEO takes charge.

“Gavin Isaacs has only been chief executive of gambling group Entain for a week and he’s already managed to issue a trading update that’s put a rocket underneath the share price,” Russ Mould said.

“Trading has been good in recent months, helping to restore market confidence in the company’s ability to bounce back after a patchy few years.

“Isaacs will certainly welcome a more positive backdrop as there was a big risk he was wading immediately into quicksand on the first day of the job, having to fight hard to stop the business sinking further into the ground.

Burberry was the top faller, shedding 5%, as it was confirmed that the luxury label will exit the FTSE 100 effective 23rd September. Barclays analysts added to the group’s woes by cutting Burberry to underweight with a new price target of 540p.

Burberry now trades at the lowest levels since 2009 amid a broad decline in luxury fashion brands globally.

ASA International – Shares On 6 Times Current Year And 4.5 Times Prospective, Offering 50% Upside 

You have to admit that Bill Gates is no fool. 

Having made absolute fortunes out of identifying and then developing Microsoft, with his wife he started to use part of their joint wealth to help the world’s needy. 

Way back in 2007, the Bill and Melinda Gates Foundation made a $20m loan to the thennewly formed ASA International Group (LON:ASAI)

Today that company is one of the world’s largest international microfinance institutions, with a strong commitment to financial inclusion and socio-economic progress. 

Towards the end of this month, on Friday 27th September, it will be declaring its Interim Results for the period to end-June, which I believe will show a useful advance in the group’s activities. 

What Is Microfinance? 

Microfinance is the provision of financial services to the poor.  

This involves small amounts of savings, credit, insurance and money transfer services.  

There is significant net demand for such financial services in many areas of the developing world, especially in rural areas.  

The Business 

Through its heritage and close association with ASA, the Association of Social Advancement, based in Bangladesh, the group has a long heritage in the microfinance industry.  

From inception, it benefited from early access to ASA NGO Bangladesh’s know-how, industry technical expertise and experts.  

The company was founded to adapt the ASA Model to fit the diverse countries in Asia and Africa in which it has established its microfinance institutions. 

The ASA operating (lending) model is focused on six distinctive features, emphasising the group’s social responsibility commitment to clients and staff:  

  • Loans with market-based interest rates.  
  • Group selection without joint liability.  
  • Collateral-free loans with a moratorium on loan repayments in emergency situations.  
  • Loans for income-generating activity only.  
  • Full repayment before qualifying for new loans and repeat loan cycles with set limits.  
  • Training and development of operating staff in-house and no bonus incentive. 

The company provides small, socially responsible loans to low-income, financially underserved entrepreneurs, predominantly women, across South Asia, Southeast Asia, West and East Africa.  

It provides small socially responsible loans, bank accounts, savings and other financial services to start or grow businesses.  

Managing credit risk is an integral part of the group’s operating model.  

Its loan officers foster close client relationships, quickly identifying repayment or other issues, as well as disbursing new, higher loans to qualified clients.  

The client assessment and admission process takes up to 14 days for a first cycle loan, ensuring only clients committed and able to grow their businesses are accepted and protecting clients from being over-leveraged.  

The credit methodology results in low credit costs, which in combination with the low cost of operations, leads to attractive financial returns.  

The company maintains a favourable maturity profile with the average tenor of all funding from third parties being substantially longer than the average tenor at issuance of loans to customers, which ranges from 6-12 months. 

Today it has over 2,016 branches, across 13 countries, handling its 2.3m clients.  

It operates in Pakistan, India, Sri Lanka, The Philippines, Myanmar, Ghana, Nigeria, Sierra Leone, Tanzania, Kenya, Uganda, Rwanda and Zambia. 

The impact of principal risks on its business is different from country-to-country, which benefits the group.  

The group’s risk profile is diversified across those thirteen markets in Asia and Africa.  

Addressable Market 

According to the World Bank, the addressable market is estimated at 378m prospects in existing countries of operation.  

The group is well placed to capture this significant breadth of market opportunity by continuing to increase its penetration in current as well as in future markets in Asia and Africa.  

Latest Trading Update 

On Wednesday 17th July the company updated investors that it had seen sustained momentum in its business performance in its first half year, along with continued improvement in its operating environment, and that it expects that momentum to continue in H2 2024. 

The outlook for 2024 remains positive with continued improved business performance expected for its operations on the back of the momentum and from the continuing high demand for loans from its clients. 

It is now expected to result in an improved trading performance for 2024, which should be ahead of the current market consensus for the current financial year.  

Analyst Views 

At Stifel Nicolaus Europe, analyst Hugo Cruz has 106p Price Objective out on the group’s shares. 

While Nidhesh Jain and Sri Karthik Velamakanni at Investec Bank rate the shares as a Buy, with a 116p Price Objective, estimating the year to end-December will show revenues of $159.0m ($148.2m) and pre-tax profits of $41.9m ($38.0m), lifting earnings up to 19.3c (15.0c) per share. 

For 2025 they see $181.7m revenues, $50.3m profits and 25.6c per share earnings. 

Stephen Barrett at Cavendish Capital Markets looks for $161.2m revenues this year, with $46.4m in adjusted pre-tax profits, earnings of 18.2c or 14.3p per share, and a 3.6p (nil) dividend. 

For the coming year he goes for $180.8m revenues, $54.9m profits,24.8c or 19.4p earnings and a 5.4p dividend per share. 

Barrett has a Price Objective of 136p on the shares. 

In My View 

This is a massively scalable business that offers significant growth potential. 

In addition to its branch model, the group is looking to introduce a digital channel via mobile devices, market-by-market over the coming years.  

Furthermore, in due course the group aims to offer deposits more widely and other digital financial services in all operations, on a country-by-country basis, depending on local demand and starting in the operations with deposit-taking licenses.  

At the current 87p, this £87m capitalised group’s shares are a ‘giveaway’ trading on 6 times current year and just 4.5 times prospective earnings. 

I see at least a 50% appreciation in the near-term. 

Xeros Technology Group hits all time low as investors opt out of long wait for profit

Xeros Technology Group shares hit a fresh all-time mid-price low on Monday as investors continued to exit the stock after the company pushed out its timeline for profitability.

In a sobering trading update released last week, Xeros Technology Group plc has announced significant setbacks to its revenue and earnings outlook for the near future.

The company, known for its technologies aimed at reducing the environmental impact of clothing, faces delays in key markets and regulatory uncertainties that have forced a downward revision of its financial projections.

The update paints a grim picture of the company’s short-term prospects. Xeros has dramatically reduced its revenue expectations for FY24 and FY25 to £0.5m and £3.8m, respectively. A substantial decrease from previous forecasts.

Moreover, the adjusted EBITDA loss is now anticipated to be £4.2m for FY24 and £1.0m for FY25, indicating investors are in for a long wait for profitability.

Two major factors contribute to this negative outlook. Firstly, Xeros’s Indian domestic laundry licensee, IFB Industries Limited, has postponed the mass market launch of a 9kg washing machine incorporating Xeros technology from 2024 to 2025. This delay, coupled with a leadership change in IFB’s Home Appliances Division, has pushed back the timeline for Xeros to realise its first royalty revenues in the Indian market.

Secondly, the company has been impacted by regulatory uncertainties in France. While legislation for microfibre filtration in washing machines is in place, the standards and efficacies remain unclarified. This lack of clarity has stalled the anticipated demand for Xeros’s XF3 technology in the short term, further dampening revenue prospects.

The company projects cash balances of £2.9m at 31 December 2024, with current cash standing at £4.0m as of 30 August 2024. While the board expects this to be sufficient to finance operations until achieving month-on-month cash flow break-even in late 2025, the margin for error appears slim.

Entain builds momentum in H2 amid US platform improvements

Ahead of investor meetings this week, Entain, the global sports betting and gaming group, has released an update on its strategic progress and trading performance for the second half of 2024.

Gavin Isaacs assumed the role of Chief Executive Officer on 2 September 2024 and will lead a series of investor meetings expected to deliver upbeat developments.

BetMGM, Entain’s US sports betting platform, is finally showing signs of positivity. The platform launched an enhanced experience ahead of the 2024 NFL season, including improved parlay and player prop options powered by Angstrom’s market pricing capabilities, as well as streamlined live betting and bet slip features. BetMGM’s betting experience is very different to the one typical of European platforms and could be considered cumbersome.

BetMGM has also become the first sports betting app to offer Nevada bettors seamless, nationwide connectivity through a single digital wallet.

Investors will be delighted to learn that Entain’s gaming performance in the second half of 2024 has surpassed expectations.

The company reported that the improving momentum observed during Q2 has continued, with Online Net Gaming Revenue (NGR) growth during H2 2024 to date exceeding anticipated levels.

The UK and Ireland Online segment, which has been a worry for investors recently, has returned to year-on-year growth earlier than expected.

International and Central and Eastern European regions continue to perform well, while retail performance across all regions remains in line with expectations.

Entain shares were 5% higher at the time of writing.

Design wins accelerating growth at Concurrent Technologies

Ruggedised plug-in cards and systems developer Concurrent Technologies (LON: CNC) is benefiting from recent capital investment and product development and profit growth is starting to accelerate.
Interim revenues were 38% ahead at £16.8m, while pre-tax profit jumped from £1m to £2.3m. There was a cash outflow in the first half because of a £4.5m purchase of end of life components. The business remains underlyingly cash generative, though.
Eight major design-in contracts have been won by Concurrent Technologies during the first half. The largest was worth $4.5m.
US business Philips Aerospace ha...

Director deals: Chairman shows long-term optimism for Genus

The chairman of animal genetics company Genus (LON: GNS) and his wife have invested nearly £180,000 in share purchases since the publication of full year results at the beginning of September. The purchases are at prices well below his previous acquisitions of shares.
Catherine Ferguson bought 3,500 shares at 1763.626p each and a further 3,500 shares at 1801p each. Chairman Iain Ferguson bought 3,000 shares at 1800p each. This has more than doubled the total shareholding to 20,500.
In May 2023, Iain Ferguson bought 1,000 shares at 2479p each and in 2021 he was buying shares at prices between 4...

Aquis weekly movers: Good Life Plus partners with mobile company

Tennyson Securities has published research on Tap Global Group (LON: TAP). It is available via www.tennysonsecurities.co.uk. The share price jumped 28.6% to 0.9p.

Peninsula Yacht Services is adopting SulNOx Group (LON: SNOX) fuel additives for the fuel it supplies from its Gibraltar. The specialist pumping system is being installed following permission from the authorities. The share price improved 12.7% to 31p.

Cooks Coffee (LON: COOK) executive chairman Keith Jackson acquired 22,000 shares during July and sold 18,582 shares during August. This was via the Nikau Trust. His total stake is 19.96%. He also owns 500,000 non-voting shares. The share price moved up 8.33% to 6.5p.

Good Life Plus (LON: GDLF) raised £275,000 from a convertible loan note issue that expires on 31 August 2025 when it can be repaid at a 10% premium or converted into shares at a 10% discount to the weighted average price over the previous month. If there is £2m raised in a share issue, then the loan notes are immediately convertible at a 10% discount to the issue price. The coupon is 10%. Following this issue, a partnership was announced with a major UK mobile operator. Good Life Plus will offer promotions to help with engagement with tens of millions of subscribers. This will provide access to potential subscribers to the Good Life Plus platform. There should be other partnerships in the coming months. The share price increased 3.28% to 3.15p. This is a new high for the shar price.

FALLERS

It is taking longer than anticipated Invinity Energy Systems (LON: IES) even though the long duration energy storage market is growing. More time is required to develop the Mistral next-gen product to reduce costs. There is uncertainty about the timing of the recognition of revenues. The 2024 revenues were expected to be £36.3m, but it is likely to be lower. Jonathan Marren is replacing Larry Zulch as chief executive. There was £49.2m in the bank at the end of June 2024. The share price is 47.1% lower at 11.25p. That is a slightly larger fall than for the price on AIM, although both prices are now the same.

Quantum Exponential Group (LON: QBIT) says discussions continue with potential investors that have proposed a minimum investment of £1m at 1p/share. The investors also agreed to pay the investment company £100,000 to cover costs since incurred since the proposed cancelation was announced. This will be repayable out of the proceeds of the investment when it is completed. The general meeting has been postponed again, this time to 3 October. The share price fell by one-fifth to 0.4p.

Wishbone Gold (LON: WSBN) has appointed Tavira Financial to replace SP Angel as corporate broker. A new investor relations strategy will be announced shortly. The share price declined 7.41% to 0.625p.

Oscillate (LON: MUSH) is progressing the proposed acquisition of Quantum Hydrogen Inc. Regulatory approval of the documentation is being awaited and a general meeting should be announced this month. The share price is 7.14% lower at 1.3p.

ProBiotix Health (LON: PBX) is raising £1.2m at 3.36p/share. OptiBiotix Health (LON: OPTI) is unhappy with the latest fundraise by ProBiotix Health and claims a typo in the AGM notice means that it should not be allowed to issue more shares except on a pre-emptive basis. The company previously said that it had enough cash. ProBiotix Health believes that the error is not relevant.  The underlying problem seems to be the high discount of the fundraising price to the market price. However, the share price held up, dipping 5.56% to 4.25p.